Microvesicles derived from mesenchymal stem cells: new hope of the treatment for ARDS
10.3760/cma.j.issn.2095-4352.2017.09.002
- VernacularTitle:间充质干细胞微泡——ARDS治疗的新希望
- Author:
Qihong CHEN
;
Ruiqiang ZHENG
;
Hualing WANG
- Keywords:
Mesenchymal stem cell;
Microvesicle;
Acute respiratory distress syndrome
- From:
Chinese Critical Care Medicine
2017;29(9):774-777
- CountryChina
- Language:Chinese
-
Abstract:
Acute respiratory distress syndrome (ARDS) is a serious state threaten human health with a high mortality about 30%-40%. At present, there is no effective treatment for ARDS. Microvesicles derived from mesenchymal stem cells (MSC-MVs) have a heterogeneous subcellular structure secreted by MSCs. It plays an important role in the repair of tissue and organ damage.Recent studies have shown that MSC-MVs, played an important role in repairing lung injury, may replace MSC for cell therapy. Therefore MSC-MVs may bring new hope for ARDS treatment.
